The startup develops assistive medical robots that monitor patients' stress and endurance levels during treatment, ensuring a therapeutic experience. This technology enables healthcare providers to reduce manpower costs while maintaining high-quality patient care.
Funding
$6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare providers face challenges in delivering consistent and precise soft tissue therapy, while also managing manpower costs and ensuring optimal patient outcomes. Traditional manual therapy can be labor-intensive and subject to variability in technique and therapist fatigue.
Solution
AiTreat develops and commercializes robotic solutions for soft tissue therapeutic treatment, offering a precise and consistent alternative to manual massage therapy. Their EMMA (Expert Manipulative Massage Automation) robots are designed to assist physicians in providing therapeutic care, increasing productivity and ensuring consistent treatment quality. The robots integrate medical expertise with robotics to deliver tailored treatments with precision.
Target Audience
The primary target audience includes physicians, therapists, and healthcare providers in wellness centers, sports medicine clinics, and treatment facilities seeking to enhance the precision and consistency of soft tissue therapy while optimizing resource allocation.
Features
- EMMA 7 Pro: A precise soft tissue therapeutic treatment robot.
- Integration of medical expertise with robotics for effective treatments.
- Designed to assist physicians in providing therapeutic care.
- Provides patients with effective treatments tailored to precision and consistency.